← Open Payments lookup

DEBORAH RUSH: Open Payments

NPI 1518209196 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,973 in 125 payments from 14 companies in 2025. Trend: 2023 $2,875 · 2024 $3,169 · 2025 $2,973

Food & beverage: $2,901Education: $71
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$435
E.R. Squibb & Sons, L.L.C.11$400
Teva Pharmaceuticals USA, Inc.10$375
ABBVIE INC.30$363
Vanda Pharmaceuticals Inc.15$319
Alkermes, Inc.13$318
Otsuka America Pharmaceutical, Inc.11$226
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$196
Janssen Pharmaceuticals, Inc4$116
Corium, LLC4$79

Products named: INGREZZA, COBENFY, FANAPT, VRAYLAR, LYBALVI, REXULTI, CAPLYTA, UZEDY.

Industry payments across ID — which companies pay providers there.